Fig. 3From: Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) studySurvival curves of ibrutinib-treated patients and controls receiving conventional chemotherapy. Follow-up in monthsBack to article page